Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pharmacotherapy

Statins and new-onset diabetes mellitus—a matter for debate

Statins are effective for cardiovascular disease prevention but have recently been associated with an increased risk of new-onset diabetes mellitus. However, until this association is confirmed, treatment discontinuation is not advisable. Lifestyle measures and treatment of risk factors that often cluster with dyslipidemia could ameliorate this potential adverse effect of statins.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Culver, A. L. et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch. Intern. Med. 172, 144–152 (2012).

    Article  Google Scholar 

  2. Sattar, N. et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375, 735–742 (2010).

    Article  CAS  Google Scholar 

  3. Preiss, D. et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305, 2556–2564 (2011).

    Article  CAS  Google Scholar 

  4. Athyros, V. G., Tziomalos, K., Karagiannis, A. & Mikhailidis, D. P. Lipid-lowering agents and new onset diabetes mellitus. Expert Opin. Pharmacother. 11, 1965–1970 (2010).

    Article  CAS  Google Scholar 

  5. Verdecchia, P. et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 43, 963–969 (2004).

    Article  CAS  Google Scholar 

  6. Athyros, V. G., Tziomalos, K., Karagiannis, A. & Mikhailidis, D. P. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes? Curr. Pharm. Des. 16, 3939–3947 (2010).

    Article  Google Scholar 

  7. Athyros, V. G. et al. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology http://dx.doi.org/10.1177/0003319711421341.

  8. Waters, D. D. et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J. Am. Coll. Cardiol. 57, 1535–1545 (2011).

    Article  CAS  Google Scholar 

  9. Karagiannis, A. et al. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr. Vasc. Pharma col. 8, 792–803 (2010).

    Article  CAS  Google Scholar 

  10. Neil, H. A. et al.; CARDS Study Investigators. Analysis of efficacy and safety in patients aged 65–75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes Care 29, 2378–2384 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitri P. Mikhailidis.

Ethics declarations

Competing interests

V. G. Athyros declares no competing interests. D. P. Mikhailidis declares associations with the following companies: Genzyme, MSD (consultant, speaker).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Athyros, V., Mikhailidis, D. Statins and new-onset diabetes mellitus—a matter for debate. Nat Rev Endocrinol 8, 133–134 (2012). https://doi.org/10.1038/nrendo.2012.16

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2012.16

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing